GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Envoy Medical Inc (NAS:COCH) » Definitions » Cash Flow from Others

Envoy Medical (Envoy Medical) Cash Flow from Others : $5.05 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Envoy Medical Cash Flow from Others?

Envoy Medical's cash flow from others for the three months ended in Mar. 2024 was $1.46 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Mar. 2024 was $5.05 Mil.


Envoy Medical Cash Flow from Others Historical Data

The historical data trend for Envoy Medical's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Envoy Medical Cash Flow from Others Chart

Envoy Medical Annual Data
Trend Dec21 Dec22 Dec23
Cash Flow from Others
1.75 7.20 11.50

Envoy Medical Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only 9.49 8.79 -5.12 -0.09 1.46

Envoy Medical Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.05 Mil.

Envoy Medical Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Envoy Medical's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


Envoy Medical (Envoy Medical) Business Description

Traded in Other Exchanges
N/A
Address
4875 White Bear Parkway, White Bear Lake, MN, USA, 55110
Envoy Medical Inc is focused on designing, developing, and marketing fully implantable medical devices that improve hearing. The Company's first commercial product, the Esteem PMA application, is a fully implantable hearing device. The Esteem PMA was cleared in 2010 by the United States Food and Drug Administration. The Company intends to continue to pursue the development of a cochlear implant.